# The coherence between PSMC6 and α-ring in the 26S proteasome is associated with Alzheimer’s disease

**Authors:** Jing Xiong, Xinping Pang, Xianghu Song, Lin Yang, Chaoyang Pang

PMC · DOI: 10.3389/fnmol.2023.1330853 · Frontiers in Molecular Neuroscience · 2024-01-31

## TL;DR

This study explores how changes in the 26S proteasome, specifically PSMC6 and α-ring subunits, are linked to Alzheimer’s disease progression and proteostasis.

## Contribution

The study identifies a novel association between PSMC6 and α-ring subunit synergy and Alzheimer’s disease risk.

## Key findings

- Proteasome numbers decrease with AD progression due to downregulated hub genes.
- Remaining proteasomes show increased activity and coordination to counteract proteotoxicity.
- Synergistic downregulation of PSMC6 and α-ring subunits is linked to higher AD risk.

## Abstract

Alzheimer’s disease (AD) is a heterogeneous age-dependent neurodegenerative disorder. Its hallmarks involve abnormal proteostasis, which triggers proteotoxicity and induces neuronal dysfunction. The 26S proteasome is an ATP-dependent proteolytic nanomachine of the ubiquitin-proteasome system (UPS) and contributes to eliminating these abnormal proteins. This study focused on the relationship between proteasome and AD, the hub genes of proteasome, PSMC6, and 7 genes of α-ring, are selected as targets to study. The following three characteristics were observed: 1. The total number of proteasomes decreased with AD progression because the proteotoxicity damaged the expression of proteasome proteins, as evidenced by the downregulation of hub genes. 2. The existing proteasomes exhibit increased activity and efficiency to counterbalance the decline in total proteasome numbers, as evidenced by enhanced global coordination and reduced systemic disorder of proteasomal subunits as AD advances. 3. The synergy of PSMC6 and α-ring subunits is associated with AD. Synergistic downregulation of PSMC6 and α-ring subunits reflects a high probability of AD risk. Regarding the above discovery, the following hypothesis is proposed: The aggregation of pathogenic proteins intensifies with AD progression, then proteasome becomes more active and facilitates the UPS selectively targets the degradation of abnormal proteins to maintain CNS proteostasis. In this paper, bioinformatics and support vector machine learning methods are applied and combined with multivariate statistical analysis of microarray data. Additionally, the concept of entropy was used to detect the disorder of proteasome system, it was discovered that entropy is down-regulated continually with AD progression against system chaos caused by AD. Another conception of the matrix determinant was used to detect the global coordination of proteasome, it was discovered that the coordination is enhanced to maintain the efficiency of degradation. The features of entropy and determinant suggest that active proteasomes resist the attack caused by AD like defenders, on the one hand, to protect themselves (entropy reduces), and on the other hand, to fight the enemy (determinant reduces). It is noted that these are results from biocomputing and need to be supported by further biological experiments.

## Linked entities

- **Genes:** PSMC6 (proteasome 26S subunit, ATPase 6) [NCBI Gene 5706]
- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** PSMC6 (proteasome 26S subunit, ATPase 6) [NCBI Gene 5706] {aka RPT5, SUG2, p42}
- **Diseases:** neurodegenerative disorder (MESH:D019636), AD (MESH:D000544), neuronal dysfunction (MESH:D009461)
- **Chemicals:** ATP (MESH:D000255)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10864545/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10864545/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC10864545/full.md

---
Source: https://tomesphere.com/paper/PMC10864545